• Lead end-to-end research strategy for complex and rare disease cases, delivering clear, prioritized, evidence-based treatment pathways • Identify diagnostic gaps and recommend advanced testing strategies that refine diagnoses and inform care decisions • Evaluate standard-of-care and investigational therapies globally, including clinical trial opportunities • Translate complex medical literature into actionable, patient-friendly reports and education materials • Serve as a trusted scientific thought partner to clinicians, clients, and external experts • Analyze patient medical records, extract and track lab values, symptoms, medication histories, and clinical outcomes • Conduct deep literature searches (PubMed, Google Scholar, specialty databases), synthesize findings, compare clinical studies, and present insights in clear, accessible language • Evaluate clinical and molecular data to identify diagnostic gaps and recommend evidence-based testing strategies • Assess guidelines, emerging therapies, and investigational approaches. Identify and engage key opinion leaders and field experts to support case strategy • Search clinical trial databases, evaluate eligibility criteria, build tracking tools, and communicate with trial sites to assess opportunities • Develop high-quality written reports, presentations, spreadsheets, charts, and educational materials that guide client decision-making

• Build and operate a high-velocity, high-quality async care engine at scale • Own the end-to-end performance of the asynchronous care ecosystem (throughput, turnaround time, productivity, quality, safety, cost) • Manage a multi-layered leadership team overseeing hundreds of Medical Assistants and clinical staff • Design operational systems required to scale volume significantly faster than headcount growth • Ensure accountability and maintain clear visibility into backlog aging and operational risk

• Lead, coach, and develop a team of TLLs across the Northeast region, setting clear performance expectations and fostering continuous growth and excellence. • Deliver regular field coaching, feedback, and support through one-on-ones, field rides, and development planning and implementation. • Monitor and enhance team performance based on MBO metrics, and effectively translate activities into KPIs that demonstrate impact. • Maintain a strong culture of accountability, compliance, and strategic alignment. • Translate national brand strategy into tactical field execution plans at the zone level. • Drive flawless launch performance through the TLL team’s engagement with key Thought Leaders, execution of regional initiatives, and collection of field insights. • Identify local and regional opportunities, inform brand strategy adjustments, and ensure continuous optimization of field efforts. • Ensure aligned pull-through of commercial strategy in coordination with Sales, Marketing, Market Access and other cross-functional zone leadership partners. • Co-lead the development and field deployment of tools, training, and resources to elevate TLL effectiveness. • Collaborate with national DTLLs and HQ stakeholders to ensure field resources are aligned and impactful. • Act as a champion for innovation and feedback integration, continuously improving resources based on real-world Thought Leader input and regional needs. • Serve as a strategic thought partner to the VP of TLLs and peer DTLLs in shaping national TLL strategy, operations, and capability building. • Represent regional perspectives in cross-functional forums and help drive consistent best practices across geographies. • Collaborate closely with Marketing, Market Access, Sales Leadership, and Training to ensure integrated customer engagement and strategic alignment.

• Own end-to-end MIDD evidence strategies for a therapeutic or sub-therapeutic area, guiding data prioritisation, integration, quality assessment, and application of advanced modelling to drive scientific, program, and business decisions • Act as the MIDD technical authority, leading M&S plans, analyses, and reports, coaching internal and external analysts, and supporting regulatory interactions involving quantitative evidence • Lead the delivery of robust, transparent MIDD evidence to de-risk and accelerate programs, advising on optimized internal and regulatory MIDD strategies • Drive consistent use of established M&S methodologies (e.g., MBMA, disease progression modelling) and integrate emerging technologies (AI/ML, SciML) through standards, training, and best practices • Build strong internal and external networks across CPMS, QSP, AI/ML, digital, biomarkers, and academia to shape future methodologies and strengthen GSK’s scientific and regulatory presence